Skip to content
MedsAcross

Medicine

Alosetron 0.5 mg tablet

Alosetron · Oral
Available on requestPrescription onlyUS FDAGeneric name

Alosetron 0.5 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.

Key facts

Active ingredient (INN)
Alosetron
Brand
Sold under the generic name
Strength
0.5 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 500 tablets and 4 more
Manufacturers
Lifestar PharmaIndiaAmneal PharmaceuticalsAmneal Pharmaceuticals of New YorkAvKAREBryant Ranch PrepackEywa Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A03AE01 Alosetron
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 January 2017
Identifiers
RxCUI 259306, 403975DailyMed set ID 2927e7d0-b1b8-4944-a7e8-97b60eb9bb71, 2846a244-7540-442b-81bc-638e641497ce, d62b2c5a-1693-4e67-96d5-197e1fdc8694 +3NDC 53746-248, 70756-702, 71930-010 +3Application ANDA206647, ANDA213614, ANDA211621

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 tablet in 1 bottle70756-702-30Lifestar PharmaIndia14 September 2020
30 tablet, film coated in 1 bottle65162-248-03Amneal Pharmaceuticals2 January 2017
500 tablet, film coated in 1 bottle65162-248-50Amneal Pharmaceuticals2 January 2017
30 tablet, film coated in 1 bottle53746-248-30Amneal Pharmaceuticals of New York6 September 2023
30 tablet in 1 bottle71930-010-30Eywa Pharma1 February 2019
30 tablet, film coated in 1 bottle73190-035-30AvKARE25 July 2025
30 tablet in 1 bottle63629-2517-1Bryant Ranch Prepack29 April 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 February 2000Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Alosetron 0.5 mg tablet.

Compare 1

Other strengths and forms of Alosetron

Clinical summary

Alosetron is a serotonin-3 receptor antagonist indicated only for women with severe diarrhea-predominant irritable bowel syndrome (IBS) who have. It is available as tablets for oral use. MedsAcross supplies Alosetron for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Alosetron

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Alosetron 0.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.